Anzeige
Mehr »
Freitag, 26.12.2025 - Börsentäglich über 12.000 News
DiagnosTear: Massentaugliche Diagnose Technologien!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D3KD | ISIN: US50535E1082 | Ticker-Symbol: N/A
1-Jahres-Chart  (nicht börsennotiert)
PROSOMNUS INC Chart 1 Jahr

Aktueller Chart PROSOMNUS Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
PROSOMNUS INC-Investoren interessieren sich auch für diese Wertpapiere
Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key MetricsReports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit...
► Artikel lesen
Alignment Healthcare USA, LLC: Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for SeniorsORANGE, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2026 product portfolio, offering 68...
► Artikel lesen
Alignment Healthcare Reports Second Quarter 2025 Results; Raises Full-Year Outlook Across All Key MetricsReports total revenue of $1.0 billion in Q2 and 223,700 health plan members as of June 30, up 49.0% and 27.8% year-over-year respectively Surpasses high-end of Q2 guidance across all key metrics:...
► Artikel lesen
Progyny, Inc. Announces Third Quarter 2025 ResultsReports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and...
► Artikel lesen
Progyny, Inc.: Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and MenopauseGlobal employers can now empower their workforces with comprehensive women's health benefits, supported by localized expertiseNEW YORK, Oct. 22, 2025. (Nasdaq: PGNY), a global leader in women's health...
► Artikel lesen
Progyny, Inc. Announces Second Quarter 2025 ResultsReports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance...
► Artikel lesen
GeneDx to Participate in Upcoming Investor ConferencesGeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences: Stifel...
► Artikel lesen